nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—HRH2—gastric juice—esophageal cancer	0.425	0.655	CbGeAlD
Tolazoline—HRH2—digestive system—esophageal cancer	0.0259	0.04	CbGeAlD
Tolazoline—HRH2—lung—esophageal cancer	0.0216	0.0334	CbGeAlD
Tolazoline—ADRA1A—epithelium—esophageal cancer	0.0167	0.0258	CbGeAlD
Tolazoline—ADRA2C—bronchus—esophageal cancer	0.0157	0.0242	CbGeAlD
Tolazoline—HRH2—lymph node—esophageal cancer	0.0148	0.0228	CbGeAlD
Tolazoline—Benzyl alcohol—ALDH2—esophageal cancer	0.0145	0.756	CrCbGaD
Tolazoline—ADRA2C—trachea—esophageal cancer	0.0141	0.0217	CbGeAlD
Tolazoline—HRH1—epithelium—esophageal cancer	0.0129	0.0199	CbGeAlD
Tolazoline—ADRA2A—bronchus—esophageal cancer	0.0125	0.0193	CbGeAlD
Tolazoline—HRH1—smooth muscle tissue—esophageal cancer	0.0125	0.0192	CbGeAlD
Tolazoline—HRH1—trachea—esophageal cancer	0.0114	0.0176	CbGeAlD
Tolazoline—ADRA2A—trachea—esophageal cancer	0.0112	0.0173	CbGeAlD
Tolazoline—ADRA2C—lung—esophageal cancer	0.0101	0.0156	CbGeAlD
Tolazoline—HRH1—digestive system—esophageal cancer	0.00983	0.0152	CbGeAlD
Tolazoline—HRH1—lung—esophageal cancer	0.00821	0.0127	CbGeAlD
Tolazoline—ADRA2A—lung—esophageal cancer	0.00806	0.0124	CbGeAlD
Tolazoline—ADRA2C—lymph node—esophageal cancer	0.00691	0.0107	CbGeAlD
Tolazoline—HRH1—lymph node—esophageal cancer	0.00562	0.00867	CbGeAlD
Tolazoline—ADRA2A—lymph node—esophageal cancer	0.00552	0.00851	CbGeAlD
Tolazoline—Amphetamine—CYP2A6—esophageal cancer	0.0047	0.244	CrCbGaD
Tolazoline—ADRA2C—Signaling Pathways—AKAP13—esophageal cancer	0.000234	0.000705	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—GHRL—esophageal cancer	0.000234	0.000704	CbGpPWpGaD
Tolazoline—HRH1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000234	0.000703	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PFN1—esophageal cancer	0.000233	0.000702	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000232	0.000697	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000232	0.000696	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.00023	0.000691	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.00023	0.00069	CbGpPWpGaD
Tolazoline—ADRA1A—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.00023	0.00069	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	0.00023	0.00069	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFBR2—esophageal cancer	0.000229	0.000689	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALDH2—esophageal cancer	0.000229	0.000687	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—TPI1—esophageal cancer	0.000228	0.000684	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTO1—esophageal cancer	0.000228	0.000684	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—NOS3—esophageal cancer	0.000225	0.000677	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—SST—esophageal cancer	0.000223	0.000671	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	0.000218	0.000656	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALDOB—esophageal cancer	0.000218	0.000656	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000218	0.000654	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GSTT1—esophageal cancer	0.000217	0.000653	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SMAD4—esophageal cancer	0.000217	0.000652	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PFN1—esophageal cancer	0.000217	0.000652	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000216	0.00065	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP2A6—esophageal cancer	0.000215	0.000646	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PDE4D—esophageal cancer	0.000214	0.000644	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ELMO1—esophageal cancer	0.000214	0.000642	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—NOS2—esophageal cancer	0.000213	0.000639	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—NOS3—esophageal cancer	0.000211	0.000633	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GAPDH—esophageal cancer	0.00021	0.000632	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ELMO1—esophageal cancer	0.00021	0.00063	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000209	0.000629	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKAP13—esophageal cancer	0.000209	0.000628	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CRABP1—esophageal cancer	0.000208	0.000626	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000205	0.000617	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKAP13—esophageal cancer	0.000205	0.000616	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	0.000205	0.000615	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GNG7—esophageal cancer	0.000204	0.000613	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ENO1—esophageal cancer	0.000204	0.000612	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS1—esophageal cancer	0.000204	0.000612	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PSME1—esophageal cancer	0.000201	0.000603	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PSME2—esophageal cancer	0.000201	0.000603	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GNG7—esophageal cancer	0.000198	0.000595	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	0.000195	0.000585	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000193	0.000581	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000193	0.000579	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	0.000192	0.000578	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—XIAP—esophageal cancer	0.000191	0.000574	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDE4D—esophageal cancer	0.000191	0.000574	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—CREBBP—esophageal cancer	0.000191	0.000574	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	0.00019	0.000572	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000189	0.000568	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDE4D—esophageal cancer	0.000187	0.000563	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000187	0.000561	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALDH2—esophageal cancer	0.000186	0.000558	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GNG7—esophageal cancer	0.000182	0.000546	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000181	0.000543	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.00018	0.00054	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.00018	0.00054	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL2—esophageal cancer	0.00018	0.00054	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.000179	0.000537	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GNG7—esophageal cancer	0.000178	0.000536	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HIF1A—esophageal cancer	0.000178	0.000534	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTT1—esophageal cancer	0.000177	0.000531	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000176	0.000528	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.000175	0.000525	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000174	0.000523	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000174	0.000523	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP1B1—esophageal cancer	0.000173	0.000521	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000171	0.000515	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.000171	0.000514	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—XIAP—esophageal cancer	0.00017	0.000512	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—KDR—esophageal cancer	0.00017	0.000511	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.00017	0.000509	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.00017	0.000509	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	0.000168	0.000504	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	0.000168	0.000504	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—XIAP—esophageal cancer	0.000167	0.000502	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	0.000167	0.000502	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000167	0.000501	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000166	0.000498	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.000165	0.000497	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ENO1—esophageal cancer	0.000165	0.000497	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000163	0.00049	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000163	0.00049	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP19A1—esophageal cancer	0.000163	0.000489	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SST—esophageal cancer	0.000163	0.000488	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CTNNA1—esophageal cancer	0.000161	0.000484	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—EP300—esophageal cancer	0.00016	0.000481	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL2—esophageal cancer	0.00016	0.000481	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NOTCH1—esophageal cancer	0.00016	0.000481	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	0.000158	0.000476	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000158	0.000476	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000158	0.000475	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL2—esophageal cancer	0.000157	0.000472	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	0.000156	0.000468	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000155	0.000467	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000152	0.000457	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PSME2—esophageal cancer	0.00015	0.000449	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PSME1—esophageal cancer	0.00015	0.000449	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ANXA1—esophageal cancer	0.000149	0.000447	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—HMOX1—esophageal cancer	0.000149	0.000447	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000147	0.000441	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PSME2—esophageal cancer	0.000147	0.000441	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PSME1—esophageal cancer	0.000147	0.000441	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ANXA1—esophageal cancer	0.000146	0.000439	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000146	0.000439	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CREBBP—esophageal cancer	0.000145	0.000436	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SST—esophageal cancer	0.000145	0.000435	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ABCB1—esophageal cancer	0.000143	0.000429	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—EGFR—esophageal cancer	0.000143	0.000429	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SST—esophageal cancer	0.000142	0.000427	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	0.000142	0.000427	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GHRL—esophageal cancer	0.000141	0.000424	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH3—esophageal cancer	0.000141	0.000424	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP1B1—esophageal cancer	0.000141	0.000423	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FBXW7—esophageal cancer	0.000139	0.000417	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000138	0.000416	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GHRL—esophageal cancer	0.000138	0.000416	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	0.000136	0.00041	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	0.000136	0.00041	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000136	0.00041	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FBXW7—esophageal cancer	0.000136	0.000409	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000136	0.000408	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000135	0.000405	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP19A1—esophageal cancer	0.000132	0.000398	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SST—esophageal cancer	0.000132	0.000397	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—EP300—esophageal cancer	0.00013	0.000391	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NOS3—esophageal cancer	0.00013	0.00039	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000129	0.000387	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	0.000129	0.000387	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000128	0.000384	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000127	0.000381	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000127	0.00038	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH2—esophageal cancer	0.000127	0.00038	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	0.000126	0.000379	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000124	0.000373	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000124	0.000372	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000123	0.000369	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ERBB2—esophageal cancer	0.000122	0.000365	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—HMOX1—esophageal cancer	0.000121	0.000363	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	0.000119	0.000358	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	0.000118	0.000356	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ABCB1—esophageal cancer	0.000116	0.000348	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000115	0.000347	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—TP53—esophageal cancer	0.000115	0.000344	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFBR2—esophageal cancer	0.000112	0.000337	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	0.00011	0.000331	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCND1—esophageal cancer	0.000107	0.000323	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SMAD4—esophageal cancer	0.000106	0.000319	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	0.000104	0.000314	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	0.000104	0.000313	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CDKN1A—esophageal cancer	0.000104	0.000312	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000102	0.000308	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KDR—esophageal cancer	9.99e-05	0.0003	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EP300—esophageal cancer	9.88e-05	0.000297	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	9.76e-05	0.000293	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	9.69e-05	0.000291	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	9.62e-05	0.000289	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CREBBP—esophageal cancer	9.53e-05	0.000286	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	9.41e-05	0.000283	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KDR—esophageal cancer	9.33e-05	0.00028	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—esophageal cancer	9.31e-05	0.00028	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	8.79e-05	0.000264	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HIF1A—esophageal cancer	8.69e-05	0.000261	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MYC—esophageal cancer	8.61e-05	0.000259	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NOS3—esophageal cancer	8.54e-05	0.000257	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	8.53e-05	0.000256	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	8.53e-05	0.000256	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—esophageal cancer	8.42e-05	0.000253	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	8.39e-05	0.000252	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KDR—esophageal cancer	8.32e-05	0.00025	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KDR—esophageal cancer	8.16e-05	0.000245	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	8.01e-05	0.000241	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	7.97e-05	0.00024	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	7.93e-05	0.000238	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	7.83e-05	0.000235	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH1—esophageal cancer	7.83e-05	0.000235	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—esophageal cancer	7.81e-05	0.000235	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CREBBP—esophageal cancer	7.74e-05	0.000233	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	7.69e-05	0.000231	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	7.64e-05	0.00023	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KDR—esophageal cancer	7.58e-05	0.000228	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	7.49e-05	0.000225	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PIK3CA—esophageal cancer	7.31e-05	0.00022	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	7.28e-05	0.000219	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	7.15e-05	0.000215	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	7.14e-05	0.000215	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	7.14e-05	0.000214	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CREBBP—esophageal cancer	7.1e-05	0.000213	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—esophageal cancer	7.07e-05	0.000213	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—esophageal cancer	6.98e-05	0.00021	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	6.97e-05	0.000209	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NOS3—esophageal cancer	6.93e-05	0.000208	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	6.85e-05	0.000206	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	6.8e-05	0.000204	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	6.68e-05	0.000201	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	6.67e-05	0.0002	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.54e-05	0.000197	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—EP300—esophageal cancer	6.49e-05	0.000195	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	6.47e-05	0.000195	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	6.36e-05	0.000191	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOS3—esophageal cancer	6.36e-05	0.000191	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—esophageal cancer	6.34e-05	0.000191	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	6.31e-05	0.00019	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	6.24e-05	0.000188	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	6.11e-05	0.000184	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.08e-05	0.000183	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	6.06e-05	0.000182	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ERBB2—esophageal cancer	5.95e-05	0.000179	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	5.94e-05	0.000179	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	5.9e-05	0.000177	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	5.84e-05	0.000175	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EP300—esophageal cancer	5.81e-05	0.000175	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	5.8e-05	0.000174	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	5.71e-05	0.000171	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	5.52e-05	0.000166	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EP300—esophageal cancer	5.43e-05	0.000163	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	5.42e-05	0.000163	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—EP300—esophageal cancer	5.27e-05	0.000158	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCND1—esophageal cancer	5.25e-05	0.000158	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	5.16e-05	0.000155	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	5.08e-05	0.000153	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—esophageal cancer	5.06e-05	0.000152	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	4.99e-05	0.00015	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	4.95e-05	0.000149	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EP300—esophageal cancer	4.84e-05	0.000145	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CA—esophageal cancer	4.8e-05	0.000144	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	4.79e-05	0.000144	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EP300—esophageal cancer	4.75e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—esophageal cancer	4.73e-05	0.000142	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	4.63e-05	0.000139	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	4.63e-05	0.000139	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EP300—esophageal cancer	4.41e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	4.3e-05	0.000129	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—esophageal cancer	4.21e-05	0.000127	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—esophageal cancer	4.16e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—esophageal cancer	4.14e-05	0.000124	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—esophageal cancer	4.12e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	4.05e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	4.02e-05	0.000121	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CA—esophageal cancer	3.9e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—esophageal cancer	3.89e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—esophageal cancer	3.84e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	3.76e-05	0.000113	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	3.58e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	3.51e-05	0.000106	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—esophageal cancer	3.46e-05	0.000104	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—esophageal cancer	3.4e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	3.26e-05	9.8e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—esophageal cancer	3.16e-05	9.48e-05	CbGpPWpGaD
